Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |